Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial
SLEEPJ · 2026
DOI: 10.1093/sleep/zsaf342 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift SLEEPJ, 2026. Verfasst von Constance H Fung und 13 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Wearable Electronic Devices, Continuous Positive Airway Pressure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Study Objectives This pilot randomized trial measured the effects of a consumer-grade wearable-augmented program, which provides nightly pulse oximetry data to patients in a weekly report, on positive airway pressure (PAP) use in adults with obstructive sleep apnea (OSA) recruited from an outpatient sleep center.
Methods
This single-blind, parallel, two-group waitlist-controlled, single-site randomized trial recruited individuals with OSA with insufficient PAP use from a Department of Veterans Affairs medical center and randomized them to immediate participation in the consumer wearable-augmented self-monitoring program versus waitlist. The primary outcome was the change in modem-measured PAP use (mean hours or minutes per night over a 7-day period) from baseline (T1) to T3 assessment, which was 35 days following randomization (7 days post-intervention for the immediate group and prior to intervention for the waitlist group).
Results
We randomized 50 participants (mean age 47.9 years [SD 11.4]; 88% male). The change in PAP use was +1.33 hours (+79.8 minutes) for the immediate group and −0.17 hours (−10.2 minutes) for the waitlist control group, with a between-group difference of 1.50 hours (90 minutes) (p = .0097). The change in the number of days PAP was used for 4 hours or more over a 7-day period was +1.32 days for the immediate and 0.12 days for the waitlist control group, with a between-group difference of 1.20 (p = .0401).
Conclusions
This pilot trial demonstrated that the consumer-grade wearable-augmented program is a promising intervention for increasing PAP use. A future full-scale trial that follows participants for a longer period is needed. Statement of Significance This pilot trial tested a novel use of the pulse oximetry feature available on some consumer-grade wearable devices to increase use of positive airway pressure (PAP) devices among adults with obstructive sleep apnea (OSA) and insufficient PAP use. The widespread and growing use of consumer-grade wearable devices offers an opportunity to leverage the features on these devices to tackle a common, problematic issue among individuals with OSA—insufficient use of PAP therapy. The randomized controlled design provides support for future research involving these devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Geriatric Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
- Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States.
- Center for the Study of Healthcare Innovation, Implementation and Policy, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
- Department of Internal Medicine, VA Connecticut and Yale School of Medicine, West Haven, CT, United States.
- Department of Medicine Statistics Core, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States.
- Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV, United States.
ORCID-Profile: Constance H Fung, Selene Mak, Sara Ghadimi, Vivian Chan, Li-Jung Liang
Förderung
- NIA NIH HHS
Zitieren
APA
Fung, C. H., Mak, S., Ash, G., Der-McLeod, E., Jason Ereso, B. S., Naeem, S., Liu, J., Ghadimi, S., Te, T. T., Chan, V., Hurtado, J., Wong, S., Zeidler, M., & Liang, L. J. (2026). Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial. SLEEPJ. https://doi.org/10.1093/sleep/zsaf342
Vancouver
Fung CH, Mak S, Ash G, Der-McLeod E, Jason Ereso BS, Naeem S, et al. Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial. SLEEPJ. 2026. doi:10.1093/sleep/zsaf342
BibTeX
@article{Fung2026,
author = {Fung, Constance H and Mak, Selene and Ash, Garrett and Der-McLeod, Erin and Jason Ereso, B S and Naeem, Saadia and Liu, Jinhui and Ghadimi, Sara and Te, Tue T and Chan, Vivian and Hurtado, Jennifer and Wong, Sarah and Zeidler, Michelle and Liang, Li-Jung},
title = {Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial},
journal = {SLEEPJ},
year = {2026},
doi = {10.1093/sleep/zsaf342}
}
EUVIMED